Journal of the American College of Cardiology
Effect of Vutrisiran According to Baseline Tafamidis Use in Transthyretin Amyloidosis With Cardiomyopathy: Insights From HELIOS-B
Trial in peopleInterventions
Papers by Brian M. Drachman
2 results
- AHA Scientific Sessions 2025 Abstract
Acoramidis Improved Clinical Outcomes, Function, Quality of Life and NT-proBNP in Patients With Transthyretin Amyloid Cardiomyopathy Regardless of Atrial Fibrillation Status at Baseline
Trial in peopleInterventions